A Considerable Setback For Cancer Trials Because Of COVID-19, IQVIA/CRI Survey Finds

 
• By Jessica Merrill

Patient enrollment in clinical trials for cancer drugs was "severely" affected by the COVID-19 pandemic, according to a report published in Nature Reviews Drug Discovery. 

Mobile Electronic Traffic Sign stating “expect Delays” taken at sunset with traffic blurred driving past the sign and traffic cones
Clinical trial enrollment issues are affecting cancer drug development • Source: Shutterstock

More from Clinical Trials

More from R&D